The post How Tax-Loss Harvesting Shapes Bitcoin’s Year-End Price Action appeared on BitcoinEthereumNews.com. Year-end crypto selling stems from tax optimizationThe post How Tax-Loss Harvesting Shapes Bitcoin’s Year-End Price Action appeared on BitcoinEthereumNews.com. Year-end crypto selling stems from tax optimization

How Tax-Loss Harvesting Shapes Bitcoin’s Year-End Price Action

For feedback or concerns regarding this content, please contact us at [email protected]
  • Year-end crypto selling stems from tax optimization strategies, not panic moves.
  • Wash sale rules don’t apply to cryptocurrencies, enabling immediate repurchases.
  • Institutional window dressing and thin holiday liquidity amplify price declines.

Bitcoin price action at year-end follows predictable patterns driven by financial incentives rather than market sentiment. Crypto Rover highlighted on X that coordinated selling pressure occurs each December as investors execute tax strategies. Understanding these mechanics explains why January often brings price rebounds.

The selling activity that investors observe is not random. It results from tax incentives, institutional reporting requirements, and reduced market liquidity during holiday periods. Retail investors frequently assume this shows holiday spending needs, but the actual drivers are sophisticated financial maneuvers that recur annually.

Tax-loss Harvesting Drives December Selling Pressure

The primary catalyst for year-end crypto sales is tax-loss harvesting. Investors deliberately sell assets trading below their purchase price to realize capital losses. These losses offset gains from other investments, reducing total tax liability for the year.

Cryptocurrency enjoys a major regulatory advantage compared to traditional securities. In the U.S. stock market, the IRS wash sale rule prevents investors from claiming tax deductions if they repurchase the same security within 30 days of selling it at a loss. As of late 2025, this rule still does not explicitly apply to cryptocurrencies in the United States.

This creates an opportunity for crypto investors to execute aggressive tax strategies. They can sell losing positions today to secure tax deductions, then repurchase the same assets to maintain market exposure. The result is massive temporary selling volume that typically reverses in January once harvesting completes.

For example, an investor who purchased Bitcoin for $1.2 million can sell at $1.0 million to realize a $200,000 loss. This loss can be claimed as a tax write-off or carried forward to future years. The investor then repurchases Bitcoin in January, maintaining their position while getting the tax benefit. These coordinated buybacks have fueled Bitcoin price rebounds at the start of each year since 2023.

Institutional Behavior and Liquidity Conditions Amplify Volatility

Professional fund managers engage in window dressing as they prepare year-end reports for clients. Managers sell underperforming assets so these holdings don’t appear on annual statements sent to investors.

They avoid having to explain why they held tokens that declined 40% during the year. Conversely, they may increase positions in top performers to show they own winning assets. This selling of losers creates downside pressure on weaker cryptocurrencies.

Portfolio rebalancing adds additional selling pressure. If Bitcoin rallied 100% while other assets remained flat, disciplined portfolio managers must sell some Bitcoin to reset allocations to target percentages. Many traders also close leveraged positions before holidays to avoid monitoring markets during family time.  

Related: 2025 Marked Crypto’s Hard Reset as Institutions Took Control

Disclaimer: The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.

Source: https://coinedition.com/how-tax-loss-harvesting-shapes-bitcoins-year-end-price-action/

Market Opportunity
Notcoin Logo
Notcoin Price(NOT)
$0.0003688
$0.0003688$0.0003688
+2.41%
USD
Notcoin (NOT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09